Other conditions exist which could potentially be treated with CD2+ cell depletion or CD2-LFA3 CoB, e.g., NK-type lymphoproliferative disease of granular lymphocytes (158) or TAP deficiency (159). This evidence concerns the gene CD2 and hyperinsulinemic hypoglycemia, familial, 4.